retatrutide phase 2 trial results obesity hits 28% weight loss in 3 Retatrutide Results: 24% Weight Loss
Description
Treatment adequacy is assessed with thyroid-stimulating hormone (TSH) testing, a standard biomarker [1922]
Weight loss typically improves sexual function
Download citation Received: Accepted: Published: Version of record: Issue date: DOI:
Consistency with healthy eating habits, hydration, and physical activity plays a key role in supporting steady progress
This limitation prevents us from differentiating between low initiation rates due to physician practices versus patient-related barriers such as cost, which is particularly relevant given the high out-of-pocket expenses for these medications in Poland
